Navigation Links
AccuGenomics to Attend OneMedForum with Standardized Gene Expression Tests for Leukemia and Lung Cancer
Date:1/6/2012

WILMINGTON, N.C., Jan. 6, 2012 /PRNewswire-iReach/ -- AccuGenomics announced today that it will be attending the upcoming OneMedForum at the Sir Francis Drake hotel in San Francisco on January 9-12, coinciding with the JP Morgan Global Healthcare Conference. AccuGenomics, founded in 2010, develops and commercializes standardized gene expression tests that accurately diagnose, monitor and guide cancer treatment. Capitalizing on a high growth diagnostic market, the company offers highly differentiated solutions in molecular diagnostics for leukemia and lung cancer.

Standardization sets AccuGenomics apart in gene expression testing. The company's standardized nucleic acid quantification (SNAQ) method streamlines complex molecular diagnostic testing that meets FDA guidelines and facilitates rapid deployment in a variety of laboratory settings. SNAQ allows hundreds of robust qPCR measurements from limited patient samples. It is insensitive to the variations of instruments, laboratories and sample quality. SNAQ technology also enables bench top complex molecular testing of limited and degraded samples. Thus AccuGenomics' quantitative, reproducible and accurate numerical gene expression measurements are unparalleled.

During 2012, AccuGenomics will be pursuing FDA approval for its standardized test for Chronic Myeoloid Leukemia (CML) treatment monitoring, in collaboration with Cancer Genetics, Inc. (CGI), a leader in the personalization of cancer treatment. CGI will offer the test in their CLIA lab as a CLIA approved test in early 2012. It accurately monitors treatment efficiency in CML patients previous diagnosed with a BCR-ABL fusion gene event. CML is not currently curable but can be controlled with established conventional drug therapies in most patients. Accurate measurements of BCR-ABL fusion transcript are critical to managing CML in those patients who have advanced to accelerated and blast phases as a result of poor response to treatment.

"The field of molecular diagnostics has been seeking a broadly applicable method of standardization to facilitate comparability of data across all labs and platforms," said Dr. Nick Lazaridis, President of AccuGenomics. "Our leading-edge diagnostic solutions in oncology fill that need. We look forward to making new strides in gene expression testing in 2012."

# # #
About AccuGenomics
AccuGenomics is a diagnostic company focused on developing standardized molecular diagnostic tests in oncology utilizing its patented technology. These gene expression tests will generate disease specific data that provide accuracy and intrinsic quality control for patient solutions. Additional information: http://www.accugenomics.com.

Media Contact: Manfred Frey AccuGenomics Inc., 910.332.6522, manfred.frey@pareto-equity.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE AccuGenomics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
2. DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey
3. DATATRAK Attends 13th Annual DIA Workshop in Japan for Clinical Data Management
4. National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees Choice New Product Awards
5. DATATRAK Attends 22nd Annual DIA EuroMeeting in Monaco
6. Winner Medical Group Inc. to Attend the 2010 Brean Murray, Carret & Co. Life Sciences Summit in New York
7. China Sky One Medical to Attend Investment Conferences in May
8. OXIS International, Inc. Announces Its Attendance at the Rodman & Renshaw Annual Global Investment Conference in London, May 16-18, 2010
9. Inverness Medical Innovations to Attend the Citi Global Health Care Conference on May 26, 2010
10. Inverness Medical Innovations to Attend the Jefferies 2010 Global Life Sciences Conference on June 8, 2010
11. Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... NEW YORK , March 27, 2017 ... mixed colors as the NASDAQ Composite closed the trading ... 0.29% lower; and the S&P 500 was down 0.08%. ... of nine sectors finishing the day in green. Pre-market ... stocks: Wright Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation ...
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... -- Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that its Board ... as Impax,s President and Chief Executive Officer and a ... Mr. Bisaro will succeed J. Kevin Buchi , ... Officer since December of 2016. With ... Bisaro, 56, is an accomplished global business leader who ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... today announced the release of two biometric time and attendance tracking products: the ... 4.0 software. NCheck Cloud Bio Attendance uses biometric face recognition to enable ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... The Executives, ... to raise money to for the Toys for Tots Literacy Campaign at their Semi-Annual ... in excess of $70 billion, the U.S. ranks at number 14 internationally in literacy. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon ... is thrilled to offer the recently FDA-approved Obalon Balloon System to his patients. ... SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu is ...
(Date:3/28/2017)... Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... treatment, is proud to announce a new blog post about women’s hair loss. Although ... suffer from hair loss as they age. Menopause or genetics can be two reasons ...
(Date:3/28/2017)... ... , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. “A ... his parents and teachers had asked of him that he had neglected to do, but ... the Almighty Creator. There were some who would have felt themselves to be special and ...
Breaking Medicine News(10 mins):